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Japanese Adult Hypopituitarism Questionnaire （JAHQ）が有用で





要旨：症例は 43 歳女性．分娩時大量出血の後，産褥 2 か月目の乳汁分泌不全を主訴に受診した．内分
泌負荷試験と画像検査の結果，Sheehan 症候群と診断し，無月経に対し Kaufmann 療法を開始した．自
覚症状がなかったため，他のホルモン補充は行わず経過観察とした．1 年後の内分泌学的検査では，変
化を認めなかった．しかし，成人下垂体機能低下症 QOL 尺度（Japanese Adult Hypopituitarism Question-
naire; JAHQ）が 100 点満点中 51.5 点と低値であったため，診断から 13 か月後に潜在性副腎皮質機能低
下症に対しヒドロコルチゾン 5mg/ 日の内服を開始した．その後，JAHQ の順調な改善を認めた．JAHQ
を用いて軽微な症状を拾い上げることが患者 QOL の正確な評価や治療開始の判断に有効であった．

































現病歴： 2 経妊 2 経産．当院にて妊娠 39 週 0 日
に頭位経腟分娩となった．低置胎盤のため胎盤娩
出後より約 5L の大量出血を認め，出血性ショッ
クを来した（産科 DIC score 11 点）．合計濃厚赤























TP 5.9g/dl WBC 6200/µl
Alb 3.7g/dl RBC 3.11 × 106/µl
AST 26IU/l Hb 9.4g/dl
ALT 36IU/l HCT 27.5%
ALP 171IU/l MCV 88fl
r-GTP 11IU/l MCH 30.2pg
BUN 10.5mg/dl MCHC 34.2%
Cr 0.59mg/dl 血小板 20.8 × 104/µl
Na 142mmol/l その他
K 3.4mmol/l P-Osm 286mOsm/l











GH（基準値 0.13-9.88） 0.03ng/ml 0.03ng/ml









U-Osm 613mOsm/l 628mOsm/l 
図 1　負荷試験（四者負荷試験）





















学的検査（表 2，1 年後；図 3）：基礎値に変化なく，
ホルモン負荷試験の結果も初回と著変なく，Cor-
tisol・TSH の反応低下を認めた．ACTH 11.6pg/ml，
Cortisol 7.7µg/dl と副腎皮質機能は 1 年前よりも











めなかった．JAHQ は 1 か月後 62.8 点，5 ヶ月後
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A case of Sheehan syndrome with subclinical adrenocortical insufficiency showing the 
utility of the Japanese Adult Hypopituitarism Questionnaire(JAHQ)
Division of Diabetes, Endocrinology, Nephrology and Rheumatology, Japanese Red Cross Kyoto Daini Hospital
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Abstract
　We herein report a case of a 43-year-old female who developed hypogalactia 2 months after 
vaginal delivery with massive hemorrhaging. She was diagnosed with Sheehanʼs syndrome based 
on the results of stimulation tests of pituitary hormones and imaging tests and received Kaufmannʼ
s therapy for the treatment of amenorrhea. Other hormone-replacing therapies were not performed 
because she had no subjective symptoms. One year later, there was no change in the endocrinological 
examination. However, the score of the Japanese Adult Hypopituitarism Questionnaire (JAHQ) was 
low at 51.5 points, which prompted us to start 5 mg/day of hydrocortisone-replacing therapy for her 
subclinical adrenocortical insufficiency 13 months after the diagnosis. After that, her JAHQ score 
improved steadily. The JAHQ is useful for evaluating a patientʼs quality of life, picking up minor 
symptoms and helping to determine treatment policy.
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